Phase III studies to investigate survodutide for people living with obesity and overweight
Boehringer Ingelheim and Zealand Pharma have initiated three Phase III trials investigating survodutide (also known as BI 456906) for...
top of page
Browse by category
Search
Zealand Pharma gain FDA approval for Zegalogue (dasiglucagon) injection for hypoglycaemia
Zealand Pharma has received approval from the FDA for Zegalogue (dasiglucagon) injection, for the treatment of severe hypoglycaemia in...
Browse by tag
bottom of page